Efficacy of Adoptive T-Cell Therapy Is Improved by Treatment With the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-Cell Death

Cancer Research - United States
doi 10.1158/0008-5472.can-16-0587
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Adoptive T-Cell Therapy for Solid Tumors

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2017English

Differential Ability of T Cell Subsets to Undergo Activation-Induced Cell Death

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1997English

Susceptibility to Cell Death Is a Dominant Phenotype: Triggering of Activation-Driven T-Cell Death Independent of the T-Cell Antigen Receptor Complex.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1992English

T Helper Lymphocytes Rescue CTL From Activation-Induced Cell Death

Journal of Immunology
AllergyImmunology
2006English

The Role of TCR Engagement and Activation-Induced Cell Death in Sepsis-Induced T Cell Apoptosis

Journal of Immunology
AllergyImmunology
2006English

Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination

Frontiers in Immunology
AllergyImmunology
2016English

Adoptive T Cell Therapy: An Overview of Obstacles and Opportunities

Cancer
Cancer ResearchOncology
2017English

Activation-Induced Non-Responsiveness (Anergy) Limits CD8 T Cell Responses to Tumors

Seminars in Cancer Biology
Cancer Research
2007English

CD8 T Cell Priming in the Presence of IFN- Renders CTLs With Improved Responsiveness to Homeostatic Cytokines and Recall Antigens: Important Traits for Adoptive T Cell Therapy

Journal of Immunology
AllergyImmunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy